| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Mesenchymal Stem Cells | 31 | 2021 | 1672 | 4.330 |
Why?
|
| Mesenchymal Stem Cell Transplantation | 15 | 2020 | 507 | 2.920 |
Why?
|
| Biocompatible Materials | 24 | 2024 | 1702 | 2.870 |
Why?
|
| Drug Delivery Systems | 23 | 2021 | 2230 | 2.740 |
Why?
|
| Cell Culture Techniques | 17 | 2020 | 1667 | 2.050 |
Why?
|
| Tissue Adhesives | 8 | 2024 | 177 | 1.690 |
Why?
|
| Prodrugs | 4 | 2020 | 274 | 1.480 |
Why?
|
| Adhesives | 3 | 2017 | 67 | 1.360 |
Why?
|
| Polyglycolic Acid | 9 | 2016 | 407 | 1.170 |
Why?
|
| Tissue Engineering | 18 | 2017 | 1893 | 1.120 |
Why?
|
| Nanoparticles | 11 | 2024 | 1983 | 1.020 |
Why?
|
| Stem Cells | 10 | 2022 | 3537 | 1.020 |
Why?
|
| Organoids | 4 | 2022 | 743 | 1.010 |
Why?
|
| Lactic Acid | 9 | 2016 | 1140 | 0.890 |
Why?
|
| Paneth Cells | 3 | 2022 | 100 | 0.880 |
Why?
|
| Regenerative Medicine | 7 | 2019 | 313 | 0.880 |
Why?
|
| Cell Adhesion | 14 | 2015 | 3096 | 0.860 |
Why?
|
| Polymers | 11 | 2019 | 1627 | 0.850 |
Why?
|
| Respiratory Protective Devices | 1 | 2023 | 47 | 0.840 |
Why?
|
| Maleimides | 2 | 2021 | 112 | 0.830 |
Why?
|
| Needles | 4 | 2019 | 461 | 0.820 |
Why?
|
| Cell Movement | 13 | 2015 | 5209 | 0.800 |
Why?
|
| Pediatric Dentistry | 4 | 2022 | 25 | 0.780 |
Why?
|
| Nanostructures | 7 | 2017 | 553 | 0.720 |
Why?
|
| Receptors, G-Protein-Coupled | 4 | 2017 | 1247 | 0.720 |
Why?
|
| Surface Properties | 16 | 2014 | 1165 | 0.670 |
Why?
|
| P-Selectin | 8 | 2013 | 598 | 0.660 |
Why?
|
| Hydrogels | 8 | 2019 | 744 | 0.660 |
Why?
|
| Animals | 89 | 2024 | 169225 | 0.650 |
Why?
|
| Intestinal Mucosa | 7 | 2024 | 3044 | 0.640 |
Why?
|
| Biosensing Techniques | 4 | 2014 | 662 | 0.610 |
Why?
|
| Injections | 2 | 2019 | 840 | 0.610 |
Why?
|
| Nanomedicine | 7 | 2018 | 292 | 0.610 |
Why?
|
| Liposomes | 3 | 2024 | 790 | 0.600 |
Why?
|
| Osteoblasts | 4 | 2014 | 1145 | 0.600 |
Why?
|
| Gastropoda | 1 | 2017 | 9 | 0.600 |
Why?
|
| Tooth Avulsion | 2 | 2006 | 5 | 0.550 |
Why?
|
| Cell Transplantation | 2 | 2010 | 475 | 0.550 |
Why?
|
| Benzylisoquinolines | 1 | 2016 | 15 | 0.550 |
Why?
|
| Biotechnology | 1 | 2018 | 283 | 0.540 |
Why?
|
| Chemotaxis | 4 | 2015 | 600 | 0.530 |
Why?
|
| Regeneration | 8 | 2024 | 1524 | 0.530 |
Why?
|
| Inflammation | 10 | 2018 | 10872 | 0.520 |
Why?
|
| Intestines | 4 | 2022 | 1908 | 0.510 |
Why?
|
| Mucus | 1 | 2017 | 347 | 0.500 |
Why?
|
| Microfluidics | 6 | 2016 | 672 | 0.500 |
Why?
|
| Materials Testing | 7 | 2019 | 873 | 0.500 |
Why?
|
| Pyloric Antrum | 1 | 2015 | 66 | 0.500 |
Why?
|
| Encephalomyelitis, Autoimmune, Experimental | 1 | 2021 | 822 | 0.490 |
Why?
|
| Nanofibers | 2 | 2019 | 68 | 0.490 |
Why?
|
| Aptamers, Nucleotide | 3 | 2011 | 163 | 0.490 |
Why?
|
| Cell Communication | 4 | 2016 | 1660 | 0.480 |
Why?
|
| Indoles | 2 | 2021 | 1835 | 0.470 |
Why?
|
| Immunosuppressive Agents | 4 | 2019 | 4210 | 0.470 |
Why?
|
| Biomimetics | 2 | 2015 | 172 | 0.470 |
Why?
|
| Oligosaccharides | 3 | 2011 | 407 | 0.460 |
Why?
|
| Transplantation, Heterologous | 2 | 2021 | 2392 | 0.460 |
Why?
|
| Dentists | 1 | 2016 | 176 | 0.460 |
Why?
|
| Insulin-Secreting Cells | 1 | 2021 | 899 | 0.450 |
Why?
|
| Electric Power Supplies | 1 | 2014 | 96 | 0.450 |
Why?
|
| Behavior Control | 1 | 2014 | 46 | 0.450 |
Why?
|
| Dental Care for Children | 1 | 2014 | 55 | 0.440 |
Why?
|
| Burns, Chemical | 1 | 2014 | 123 | 0.440 |
Why?
|
| Single-Cell Analysis | 2 | 2018 | 2543 | 0.430 |
Why?
|
| Adrenoleukodystrophy | 1 | 2015 | 144 | 0.430 |
Why?
|
| Indoleamine-Pyrrole 2,3,-Dioxygenase | 1 | 2014 | 117 | 0.430 |
Why?
|
| Porcupines | 1 | 2012 | 2 | 0.430 |
Why?
|
| Wound Healing | 8 | 2024 | 2801 | 0.430 |
Why?
|
| Ferric Compounds | 2 | 2012 | 376 | 0.430 |
Why?
|
| Elastomers | 2 | 2012 | 69 | 0.430 |
Why?
|
| Cells, Cultured | 20 | 2016 | 19015 | 0.430 |
Why?
|
| Stem Cell Transplantation | 5 | 2017 | 1596 | 0.420 |
Why?
|
| Animal Structures | 1 | 2012 | 26 | 0.420 |
Why?
|
| Budesonide | 1 | 2014 | 162 | 0.420 |
Why?
|
| Small Molecule Libraries | 2 | 2016 | 742 | 0.420 |
Why?
|
| Decanoates | 4 | 2019 | 55 | 0.410 |
Why?
|
| Genetic Engineering | 3 | 2019 | 935 | 0.410 |
Why?
|
| Dental Care | 1 | 2016 | 285 | 0.410 |
Why?
|
| Receptor, Notch1 | 1 | 2015 | 518 | 0.400 |
Why?
|
| Leukocyte Rolling | 2 | 2010 | 69 | 0.400 |
Why?
|
| Polyglactin 910 | 1 | 2012 | 56 | 0.400 |
Why?
|
| Extracellular Matrix | 3 | 2024 | 1739 | 0.400 |
Why?
|
| Skin Absorption | 2 | 2017 | 96 | 0.400 |
Why?
|
| Microscopy, Electron, Scanning | 7 | 2011 | 943 | 0.390 |
Why?
|
| Skin Physiological Phenomena | 1 | 2012 | 193 | 0.390 |
Why?
|
| Long QT Syndrome | 2 | 2006 | 472 | 0.380 |
Why?
|
| Receptors, Notch | 2 | 2017 | 751 | 0.380 |
Why?
|
| Microfluidic Analytical Techniques | 3 | 2013 | 820 | 0.380 |
Why?
|
| Glycerol | 4 | 2019 | 274 | 0.380 |
Why?
|
| Tooth, Unerupted | 1 | 2011 | 5 | 0.370 |
Why?
|
| Cell Tracking | 2 | 2011 | 140 | 0.370 |
Why?
|
| Endothelial Cells | 4 | 2013 | 3589 | 0.370 |
Why?
|
| Cell Proliferation | 14 | 2021 | 10471 | 0.370 |
Why?
|
| Cytological Techniques | 2 | 2011 | 217 | 0.360 |
Why?
|
| Dermatitis, Contact | 1 | 2011 | 134 | 0.360 |
Why?
|
| Engineering | 1 | 2011 | 56 | 0.350 |
Why?
|
| Humans | 113 | 2024 | 767998 | 0.350 |
Why?
|
| Nickel | 1 | 2011 | 126 | 0.350 |
Why?
|
| Embryoid Bodies | 1 | 2011 | 66 | 0.350 |
Why?
|
| Muscles | 2 | 2012 | 1582 | 0.350 |
Why?
|
| Microscopy, Confocal | 5 | 2019 | 1972 | 0.350 |
Why?
|
| Foreign Bodies | 1 | 2014 | 403 | 0.350 |
Why?
|
| Drug Carriers | 6 | 2018 | 708 | 0.350 |
Why?
|
| Enzyme Inhibitors | 1 | 2021 | 3726 | 0.340 |
Why?
|
| Osteogenesis | 5 | 2011 | 1288 | 0.340 |
Why?
|
| Colon | 3 | 2015 | 1800 | 0.340 |
Why?
|
| Mice, Inbred BALB C | 6 | 2015 | 6232 | 0.340 |
Why?
|
| Nanotechnology | 6 | 2017 | 714 | 0.330 |
Why?
|
| Bandages | 1 | 2011 | 271 | 0.330 |
Why?
|
| Mice | 32 | 2024 | 82024 | 0.330 |
Why?
|
| Chelating Agents | 1 | 2011 | 385 | 0.330 |
Why?
|
| Bone Marrow Cells | 5 | 2016 | 2415 | 0.330 |
Why?
|
| Signal Transduction | 10 | 2024 | 23640 | 0.330 |
Why?
|
| Dimethylpolysiloxanes | 3 | 2016 | 143 | 0.320 |
Why?
|
| Eating | 2 | 2021 | 1542 | 0.320 |
Why?
|
| Physician's Role | 1 | 2016 | 925 | 0.320 |
Why?
|
| Skin | 6 | 2019 | 4502 | 0.310 |
Why?
|
| Drug Compounding | 5 | 2020 | 240 | 0.310 |
Why?
|
| Cell Survival | 8 | 2021 | 5772 | 0.310 |
Why?
|
| Esophagus | 1 | 2014 | 1042 | 0.310 |
Why?
|
| Incisor | 2 | 2006 | 170 | 0.310 |
Why?
|
| Carotid Arteries | 3 | 2019 | 942 | 0.310 |
Why?
|
| Decision Support Techniques | 1 | 2018 | 2008 | 0.310 |
Why?
|
| Gastrointestinal Tract | 1 | 2014 | 839 | 0.310 |
Why?
|
| Cell Differentiation | 15 | 2022 | 11666 | 0.300 |
Why?
|
| Acrylates | 2 | 2019 | 74 | 0.300 |
Why?
|
| Mice, Inbred C57BL | 10 | 2024 | 22381 | 0.300 |
Why?
|
| Lizards | 1 | 2008 | 50 | 0.300 |
Why?
|
| Rats | 17 | 2024 | 23751 | 0.300 |
Why?
|
| Child Behavior | 1 | 2014 | 864 | 0.300 |
Why?
|
| Biomedical Engineering | 2 | 2012 | 286 | 0.290 |
Why?
|
| Interleukin-10 | 1 | 2013 | 1183 | 0.290 |
Why?
|
| Models, Biological | 4 | 2019 | 9493 | 0.290 |
Why?
|
| Drug Design | 1 | 2013 | 1045 | 0.290 |
Why?
|
| Polyethylene Glycols | 5 | 2011 | 1196 | 0.290 |
Why?
|
| Inflammatory Bowel Diseases | 3 | 2019 | 2442 | 0.290 |
Why?
|
| Intestine, Small | 1 | 2013 | 1216 | 0.280 |
Why?
|
| HL-60 Cells | 6 | 2014 | 364 | 0.280 |
Why?
|
| Glass | 1 | 2007 | 116 | 0.280 |
Why?
|
| Pressure | 2 | 2024 | 1172 | 0.270 |
Why?
|
| Flow Cytometry | 6 | 2014 | 5904 | 0.270 |
Why?
|
| Retrograde Obturation | 1 | 2006 | 15 | 0.270 |
Why?
|
| Thrombin | 3 | 2006 | 600 | 0.270 |
Why?
|
| Root Canal Filling Materials | 1 | 2006 | 27 | 0.270 |
Why?
|
| Catheters, Indwelling | 1 | 2009 | 436 | 0.270 |
Why?
|
| Dental Care for Chronically Ill | 1 | 2006 | 31 | 0.270 |
Why?
|
| Cell Physiological Phenomena | 1 | 2007 | 152 | 0.270 |
Why?
|
| Induced Pluripotent Stem Cells | 2 | 2015 | 1888 | 0.260 |
Why?
|
| Embryonic Stem Cells | 3 | 2008 | 1250 | 0.260 |
Why?
|
| Cell Membrane | 3 | 2012 | 3657 | 0.260 |
Why?
|
| Anilides | 2 | 2020 | 413 | 0.260 |
Why?
|
| Totipotent Stem Cells | 1 | 2005 | 16 | 0.260 |
Why?
|
| Equipment Design | 7 | 2019 | 3522 | 0.250 |
Why?
|
| Multiple Sclerosis | 1 | 2021 | 3250 | 0.250 |
Why?
|
| Arthritis | 1 | 2011 | 684 | 0.250 |
Why?
|
| Excipients | 2 | 2017 | 96 | 0.240 |
Why?
|
| Surgical Tape | 1 | 2024 | 5 | 0.240 |
Why?
|
| Prostatic Neoplasms | 5 | 2020 | 11101 | 0.240 |
Why?
|
| Chitosan | 1 | 2006 | 141 | 0.240 |
Why?
|
| Nasal Sprays | 1 | 2024 | 27 | 0.230 |
Why?
|
| Fibrin | 2 | 2004 | 514 | 0.230 |
Why?
|
| Glucocorticoids | 1 | 2014 | 2166 | 0.230 |
Why?
|
| Shear Strength | 2 | 2016 | 160 | 0.230 |
Why?
|
| Homeostasis | 1 | 2015 | 3348 | 0.230 |
Why?
|
| Adipocytes | 2 | 2014 | 1197 | 0.230 |
Why?
|
| Poly I-C | 1 | 2024 | 111 | 0.230 |
Why?
|
| Stem Cell Research | 2 | 2015 | 37 | 0.230 |
Why?
|
| Sus scrofa | 3 | 2014 | 430 | 0.220 |
Why?
|
| Syncope | 1 | 2006 | 431 | 0.220 |
Why?
|
| Bioreactors | 2 | 2020 | 246 | 0.220 |
Why?
|
| Diabetes Mellitus, Experimental | 2 | 2021 | 1125 | 0.210 |
Why?
|
| Neutrophils | 5 | 2020 | 3786 | 0.210 |
Why?
|
| Synovial Fluid | 2 | 2018 | 393 | 0.210 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 3115 | 0.200 |
Why?
|
| Chemokine CXCL12 | 2 | 2017 | 457 | 0.200 |
Why?
|
| Coated Materials, Biocompatible | 2 | 2017 | 311 | 0.200 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 3238 | 0.200 |
Why?
|
| Arthritis, Rheumatoid | 1 | 2018 | 3781 | 0.200 |
Why?
|
| Filtration | 1 | 2023 | 229 | 0.200 |
Why?
|
| Fluorescence | 2 | 2019 | 757 | 0.200 |
Why?
|
| Delayed-Action Preparations | 4 | 2016 | 968 | 0.200 |
Why?
|
| Genomics | 1 | 2018 | 5925 | 0.200 |
Why?
|
| Cell Separation | 5 | 2012 | 1729 | 0.200 |
Why?
|
| Kinetics | 4 | 2019 | 6328 | 0.200 |
Why?
|
| Epigenesis, Genetic | 1 | 2015 | 3834 | 0.190 |
Why?
|
| Staining and Labeling | 3 | 2011 | 1080 | 0.190 |
Why?
|
| Cell Aggregation | 3 | 2007 | 238 | 0.190 |
Why?
|
| Convection | 1 | 2021 | 30 | 0.190 |
Why?
|
| Swine | 5 | 2024 | 6002 | 0.190 |
Why?
|
| Bone Regeneration | 1 | 2004 | 438 | 0.190 |
Why?
|
| Gadolinium DTPA | 2 | 2018 | 823 | 0.190 |
Why?
|
| Pyridines | 3 | 2020 | 2893 | 0.190 |
Why?
|
| Antineoplastic Agents | 4 | 2020 | 13658 | 0.190 |
Why?
|
| Bone Substitutes | 1 | 2003 | 230 | 0.190 |
Why?
|
| Embryo, Mammalian | 1 | 2007 | 1676 | 0.180 |
Why?
|
| Enteroendocrine Cells | 1 | 2022 | 79 | 0.180 |
Why?
|
| Hearing Loss, Sudden | 1 | 2021 | 45 | 0.180 |
Why?
|
| Colitis, Ulcerative | 2 | 2024 | 1926 | 0.180 |
Why?
|
| Palliative Care | 1 | 2016 | 3642 | 0.180 |
Why?
|
| Phenotype | 6 | 2015 | 16723 | 0.180 |
Why?
|
| Masks | 1 | 2023 | 214 | 0.170 |
Why?
|
| Immunomodulation | 2 | 2016 | 549 | 0.170 |
Why?
|
| Particle Size | 3 | 2014 | 1649 | 0.170 |
Why?
|
| Green Fluorescent Proteins | 2 | 2017 | 2065 | 0.170 |
Why?
|
| Cell Line, Tumor | 9 | 2024 | 17128 | 0.170 |
Why?
|
| Immunotherapy | 3 | 2024 | 4748 | 0.170 |
Why?
|
| Diabetes Mellitus, Type 2 | 2 | 2021 | 12253 | 0.170 |
Why?
|
| Central Nervous System Diseases | 1 | 2024 | 519 | 0.170 |
Why?
|
| Stress, Mechanical | 3 | 2016 | 1676 | 0.170 |
Why?
|
| Bone Development | 1 | 2003 | 473 | 0.170 |
Why?
|
| Diphtheria Toxin | 1 | 2020 | 253 | 0.160 |
Why?
|
| DNA | 2 | 2012 | 7213 | 0.160 |
Why?
|
| Tissue Distribution | 2 | 2021 | 2299 | 0.160 |
Why?
|
| Microtechnology | 2 | 2017 | 70 | 0.160 |
Why?
|
| Syringes | 1 | 2019 | 58 | 0.160 |
Why?
|
| Epithelial Cells | 3 | 2024 | 3703 | 0.160 |
Why?
|
| Injections, Intraperitoneal | 1 | 2019 | 411 | 0.150 |
Why?
|
| Transforming Growth Factor beta | 2 | 2024 | 1995 | 0.150 |
Why?
|
| Hemostatic Techniques | 1 | 2019 | 116 | 0.150 |
Why?
|
| Anti-Inflammatory Agents | 3 | 2018 | 1804 | 0.150 |
Why?
|
| Synthetic Biology | 1 | 2020 | 187 | 0.150 |
Why?
|
| Infusion Pumps | 1 | 2019 | 162 | 0.150 |
Why?
|
| Platelet-Derived Growth Factor | 2 | 2011 | 616 | 0.150 |
Why?
|
| Adhesiveness | 2 | 2019 | 52 | 0.150 |
Why?
|
| Transplantation, Homologous | 2 | 2019 | 4838 | 0.150 |
Why?
|
| DNA, Mitochondrial | 1 | 2023 | 872 | 0.150 |
Why?
|
| Sucrose | 1 | 2018 | 157 | 0.150 |
Why?
|
| Aluminum | 1 | 2018 | 150 | 0.140 |
Why?
|
| NF-kappa B | 2 | 2016 | 2493 | 0.140 |
Why?
|
| Neoplasms | 7 | 2024 | 22369 | 0.140 |
Why?
|
| Calcium Phosphates | 2 | 2011 | 173 | 0.140 |
Why?
|
| Porosity | 1 | 2018 | 352 | 0.140 |
Why?
|
| Tacrolimus | 2 | 2019 | 751 | 0.140 |
Why?
|
| Coculture Techniques | 4 | 2016 | 1340 | 0.140 |
Why?
|
| Triamcinolone Acetonide | 1 | 2018 | 105 | 0.140 |
Why?
|
| Endosomes | 1 | 2020 | 522 | 0.140 |
Why?
|
| Injections, Subcutaneous | 1 | 2019 | 686 | 0.140 |
Why?
|
| Pluripotent Stem Cells | 2 | 2015 | 809 | 0.140 |
Why?
|
| Fluorides, Topical | 1 | 2017 | 32 | 0.140 |
Why?
|
| Collagen Type IV | 1 | 2017 | 125 | 0.140 |
Why?
|
| Myocytes, Cardiac | 1 | 2006 | 1681 | 0.140 |
Why?
|
| Injections, Epidural | 1 | 2019 | 203 | 0.140 |
Why?
|
| General Practice, Dental | 1 | 2017 | 32 | 0.140 |
Why?
|
| Dexamethasone | 2 | 2015 | 1964 | 0.140 |
Why?
|
| Transdermal Patch | 1 | 2017 | 51 | 0.140 |
Why?
|
| Rats, Sprague-Dawley | 4 | 2021 | 8120 | 0.140 |
Why?
|
| Polystyrenes | 1 | 2017 | 105 | 0.140 |
Why?
|
| Cancer Vaccines | 1 | 2024 | 1041 | 0.140 |
Why?
|
| Insulin | 3 | 2021 | 6606 | 0.140 |
Why?
|
| Respiratory Tract Infections | 1 | 2024 | 1014 | 0.130 |
Why?
|
| Drug Combinations | 2 | 2017 | 2088 | 0.130 |
Why?
|
| Angioplasty | 1 | 2019 | 355 | 0.130 |
Why?
|
| Islets of Langerhans Transplantation | 1 | 2021 | 749 | 0.130 |
Why?
|
| Zinc | 1 | 2020 | 676 | 0.130 |
Why?
|
| Speech Perception | 1 | 2021 | 510 | 0.130 |
Why?
|
| Hydrophobic and Hydrophilic Interactions | 2 | 2015 | 393 | 0.130 |
Why?
|
| Syndecan-1 | 1 | 2017 | 163 | 0.130 |
Why?
|
| Collagen | 3 | 2017 | 2641 | 0.130 |
Why?
|
| Reactive Oxygen Species | 1 | 2024 | 2149 | 0.130 |
Why?
|
| Laminin | 1 | 2017 | 405 | 0.130 |
Why?
|
| Prosthesis Design | 1 | 2003 | 2125 | 0.130 |
Why?
|
| HMGB1 Protein | 1 | 2017 | 141 | 0.120 |
Why?
|
| Tumor Necrosis Factor-alpha | 4 | 2016 | 4351 | 0.120 |
Why?
|
| Rats, Wistar | 5 | 2014 | 1888 | 0.120 |
Why?
|
| Islets of Langerhans | 1 | 2021 | 1352 | 0.120 |
Why?
|
| Hearing Loss, Sensorineural | 1 | 2021 | 783 | 0.120 |
Why?
|
| Silver Compounds | 1 | 2014 | 23 | 0.120 |
Why?
|
| Culture Media | 1 | 2017 | 898 | 0.120 |
Why?
|
| Stem Cell Niche | 1 | 2018 | 347 | 0.120 |
Why?
|
| Eye | 1 | 2019 | 712 | 0.120 |
Why?
|
| Permeability | 2 | 2017 | 725 | 0.120 |
Why?
|
| Immunity | 1 | 2021 | 1004 | 0.120 |
Why?
|
| Viscosity | 1 | 2015 | 334 | 0.120 |
Why?
|
| Quantum Theory | 1 | 2014 | 68 | 0.120 |
Why?
|
| Vena Cava, Inferior | 1 | 2018 | 463 | 0.120 |
Why?
|
| Escherichia coli | 2 | 2019 | 4215 | 0.120 |
Why?
|
| Organometallic Compounds | 1 | 2018 | 648 | 0.120 |
Why?
|
| Health Education, Dental | 1 | 2014 | 26 | 0.120 |
Why?
|
| Proteoglycans | 1 | 2017 | 809 | 0.110 |
Why?
|
| Gastrointestinal Agents | 1 | 2019 | 511 | 0.110 |
Why?
|
| Hair Cells, Auditory | 1 | 2017 | 382 | 0.110 |
Why?
|
| Molecular Imaging | 2 | 2011 | 827 | 0.110 |
Why?
|
| Membranes, Artificial | 2 | 2008 | 364 | 0.110 |
Why?
|
| Blood Platelets | 3 | 2015 | 2477 | 0.110 |
Why?
|
| Cell Lineage | 2 | 2014 | 2574 | 0.110 |
Why?
|
| Cyclooxygenase 2 | 1 | 2016 | 598 | 0.110 |
Why?
|
| Electric Conductivity | 1 | 2014 | 407 | 0.110 |
Why?
|
| Cell Line | 4 | 2020 | 15597 | 0.110 |
Why?
|
| Digestive System Surgical Procedures | 1 | 2019 | 585 | 0.110 |
Why?
|
| Fibroblasts | 4 | 2024 | 4176 | 0.110 |
Why?
|
| HLA-C Antigens | 1 | 2014 | 146 | 0.110 |
Why?
|
| Male | 25 | 2024 | 364638 | 0.110 |
Why?
|
| Endarterectomy, Carotid | 1 | 2019 | 556 | 0.110 |
Why?
|
| HLA-A Antigens | 1 | 2014 | 223 | 0.110 |
Why?
|
| Dental Research | 1 | 2014 | 61 | 0.110 |
Why?
|
| Tissue Scaffolds | 2 | 2017 | 950 | 0.110 |
Why?
|
| Amides | 1 | 2016 | 451 | 0.110 |
Why?
|
| Cyanoacrylates | 1 | 2013 | 47 | 0.110 |
Why?
|
| Plasma Cells | 1 | 2017 | 599 | 0.110 |
Why?
|
| Abdominal Wound Closure Techniques | 1 | 2013 | 34 | 0.110 |
Why?
|
| Pyrimidines | 2 | 2017 | 3046 | 0.110 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2018 | 2487 | 0.110 |
Why?
|
| Solubility | 2 | 2013 | 1083 | 0.110 |
Why?
|
| Decision Making | 2 | 2018 | 3953 | 0.110 |
Why?
|
| Binding Sites | 3 | 2012 | 6022 | 0.110 |
Why?
|
| Bioengineering | 1 | 2014 | 101 | 0.110 |
Why?
|
| Maxilla | 2 | 2006 | 486 | 0.110 |
Why?
|
| Drug Implants | 2 | 2019 | 230 | 0.110 |
Why?
|
| Dinoprostone | 2 | 2017 | 597 | 0.110 |
Why?
|
| RNA, Small Interfering | 3 | 2021 | 3428 | 0.110 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 1 | 2020 | 1621 | 0.110 |
Why?
|
| Contrast Media | 3 | 2018 | 5331 | 0.110 |
Why?
|
| Cell Migration Assays | 1 | 2012 | 22 | 0.100 |
Why?
|
| Chromogranin A | 2 | 2023 | 47 | 0.100 |
Why?
|
| Dental Caries | 1 | 2017 | 429 | 0.100 |
Why?
|
| Enzymes | 1 | 2014 | 254 | 0.100 |
Why?
|
| Poultry | 1 | 2012 | 79 | 0.100 |
Why?
|
| Phagosomes | 1 | 2014 | 198 | 0.100 |
Why?
|
| Chondrocytes | 1 | 2018 | 800 | 0.100 |
Why?
|
| Osmosis | 1 | 2012 | 103 | 0.100 |
Why?
|
| HLA-B Antigens | 1 | 2014 | 330 | 0.100 |
Why?
|
| Aorta, Thoracic | 1 | 2019 | 1110 | 0.100 |
Why?
|
| Rabbits | 1 | 2019 | 4771 | 0.100 |
Why?
|
| Cell Fractionation | 1 | 2013 | 247 | 0.100 |
Why?
|
| Stomach | 2 | 2013 | 701 | 0.100 |
Why?
|
| Catheters | 1 | 2015 | 427 | 0.100 |
Why?
|
| HLA-DR Antigens | 1 | 2014 | 609 | 0.100 |
Why?
|
| Body Piercing | 1 | 2012 | 9 | 0.100 |
Why?
|
| Jewelry | 1 | 2012 | 4 | 0.100 |
Why?
|
| Transendothelial and Transepithelial Migration | 1 | 2012 | 100 | 0.100 |
Why?
|
| Thiophenes | 1 | 2016 | 570 | 0.100 |
Why?
|
| Commerce | 1 | 2017 | 614 | 0.100 |
Why?
|
| Up-Regulation | 2 | 2015 | 4146 | 0.100 |
Why?
|
| Karyotyping | 1 | 2013 | 1176 | 0.100 |
Why?
|
| Cattle | 2 | 2015 | 3816 | 0.100 |
Why?
|
| Miniaturization | 3 | 2006 | 154 | 0.090 |
Why?
|
| Selectins | 1 | 2011 | 101 | 0.090 |
Why?
|
| Immunity, Innate | 2 | 2021 | 3079 | 0.090 |
Why?
|
| Ointments | 1 | 2011 | 58 | 0.090 |
Why?
|
| Tooth Exfoliation | 1 | 2011 | 6 | 0.090 |
Why?
|
| Tooth Eruption, Ectopic | 1 | 2011 | 6 | 0.090 |
Why?
|
| E-Selectin | 1 | 2013 | 577 | 0.090 |
Why?
|
| Mammals | 1 | 2017 | 1136 | 0.090 |
Why?
|
| Monocytes | 2 | 2018 | 2604 | 0.090 |
Why?
|
| Tooth Eruption | 1 | 2011 | 29 | 0.090 |
Why?
|
| Spectrophotometry, Ultraviolet | 1 | 2011 | 199 | 0.090 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 2015 | 1134 | 0.090 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2017 | 1120 | 0.090 |
Why?
|
| Calcium Carbonate | 1 | 2011 | 62 | 0.090 |
Why?
|
| Bivalvia | 1 | 2010 | 55 | 0.090 |
Why?
|
| Maxillofacial Injuries | 1 | 2011 | 32 | 0.090 |
Why?
|
| Biological Products | 1 | 2020 | 948 | 0.090 |
Why?
|
| Half-Life | 2 | 2009 | 651 | 0.090 |
Why?
|
| Valproic Acid | 1 | 2013 | 444 | 0.090 |
Why?
|
| L-Selectin | 1 | 2011 | 212 | 0.090 |
Why?
|
| Gingival Diseases | 1 | 2011 | 37 | 0.090 |
Why?
|
| Tooth Abnormalities | 1 | 2011 | 56 | 0.090 |
Why?
|
| Intraoperative Period | 1 | 2012 | 512 | 0.090 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2024 | 4648 | 0.090 |
Why?
|
| Chromosomes | 1 | 2013 | 578 | 0.090 |
Why?
|
| Edetic Acid | 1 | 2011 | 278 | 0.090 |
Why?
|
| Biotinylation | 1 | 2011 | 185 | 0.090 |
Why?
|
| Cochlea | 1 | 2017 | 848 | 0.090 |
Why?
|
| Elasticity | 2 | 2014 | 656 | 0.090 |
Why?
|
| Paracrine Communication | 1 | 2012 | 278 | 0.090 |
Why?
|
| Ions | 1 | 2011 | 255 | 0.090 |
Why?
|
| Jaw Diseases | 1 | 2011 | 91 | 0.090 |
Why?
|
| Sequence Analysis, RNA | 1 | 2018 | 2040 | 0.090 |
Why?
|
| Chondrogenesis | 1 | 2012 | 239 | 0.090 |
Why?
|
| Malocclusion | 1 | 2011 | 130 | 0.090 |
Why?
|
| Weight Loss | 1 | 2021 | 2721 | 0.080 |
Why?
|
| Fibronectins | 1 | 2013 | 722 | 0.080 |
Why?
|
| Solvents | 1 | 2011 | 298 | 0.080 |
Why?
|
| Professional-Family Relations | 1 | 2014 | 501 | 0.080 |
Why?
|
| Gels | 1 | 2011 | 423 | 0.080 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2015 | 1335 | 0.080 |
Why?
|
| Mice, Nude | 1 | 2016 | 3620 | 0.080 |
Why?
|
| Cytoplasm | 1 | 2014 | 1505 | 0.080 |
Why?
|
| Blood Glucose | 2 | 2021 | 6429 | 0.080 |
Why?
|
| Light | 1 | 2015 | 1358 | 0.080 |
Why?
|
| Molecular Targeted Therapy | 2 | 2018 | 2824 | 0.080 |
Why?
|
| Mouth | 1 | 2012 | 383 | 0.080 |
Why?
|
| High-Throughput Screening Assays | 1 | 2015 | 942 | 0.080 |
Why?
|
| North America | 1 | 2012 | 1289 | 0.080 |
Why?
|
| Internship and Residency | 2 | 2022 | 5953 | 0.080 |
Why?
|
| Transfection | 2 | 2014 | 5757 | 0.080 |
Why?
|
| Antibodies | 1 | 2017 | 2421 | 0.080 |
Why?
|
| Matrix Metalloproteinase 2 | 1 | 2011 | 461 | 0.080 |
Why?
|
| Streptavidin | 1 | 2008 | 81 | 0.080 |
Why?
|
| Cell Size | 1 | 2011 | 626 | 0.080 |
Why?
|
| Biomedical Research | 2 | 2015 | 3464 | 0.080 |
Why?
|
| Xylenes | 1 | 2008 | 8 | 0.080 |
Why?
|
| Magnetic Resonance Imaging | 3 | 2018 | 36743 | 0.080 |
Why?
|
| Coloring Agents | 1 | 2011 | 565 | 0.080 |
Why?
|
| Mentors | 1 | 2014 | 671 | 0.080 |
Why?
|
| Adipogenesis | 1 | 2011 | 370 | 0.070 |
Why?
|
| Graft Survival | 2 | 2019 | 3894 | 0.070 |
Why?
|
| Prostate | 1 | 2016 | 1765 | 0.070 |
Why?
|
| Blood Vessel Prosthesis Implantation | 1 | 2018 | 1456 | 0.070 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2011 | 633 | 0.070 |
Why?
|
| Carmustine | 1 | 2007 | 137 | 0.070 |
Why?
|
| Biotin | 1 | 2008 | 256 | 0.070 |
Why?
|
| Graft vs Host Disease | 1 | 2020 | 3049 | 0.070 |
Why?
|
| Insulin Resistance | 1 | 2021 | 3986 | 0.070 |
Why?
|
| Child | 6 | 2022 | 80905 | 0.070 |
Why?
|
| Serum Albumin, Bovine | 1 | 2008 | 320 | 0.070 |
Why?
|
| Time Factors | 8 | 2019 | 40210 | 0.070 |
Why?
|
| Magnetics | 1 | 2010 | 597 | 0.070 |
Why?
|
| Informed Consent | 1 | 2014 | 1010 | 0.070 |
Why?
|
| Blood Proteins | 1 | 2013 | 1191 | 0.070 |
Why?
|
| Documentation | 1 | 2014 | 917 | 0.070 |
Why?
|
| Epoxy Compounds | 1 | 2007 | 137 | 0.070 |
Why?
|
| Lipopolysaccharides | 1 | 2015 | 2219 | 0.070 |
Why?
|
| Gliosarcoma | 1 | 2007 | 115 | 0.070 |
Why?
|
| Leukocytes | 2 | 2012 | 2036 | 0.070 |
Why?
|
| Spectrum Analysis, Raman | 1 | 2009 | 253 | 0.070 |
Why?
|
| Pyrazoles | 1 | 2017 | 2028 | 0.070 |
Why?
|
| Receptors, Cell Surface | 3 | 2015 | 2819 | 0.070 |
Why?
|
| Hemorrhage | 1 | 2019 | 3467 | 0.070 |
Why?
|
| Clinical Trials as Topic | 2 | 2014 | 8052 | 0.070 |
Why?
|
| Female | 15 | 2024 | 397102 | 0.070 |
Why?
|
| Heterozygote | 1 | 2013 | 2798 | 0.070 |
Why?
|
| Colitis | 1 | 2015 | 1240 | 0.070 |
Why?
|
| Myocardial Ischemia | 1 | 2017 | 2138 | 0.070 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2021 | 3447 | 0.070 |
Why?
|
| Aldehydes | 1 | 2007 | 170 | 0.070 |
Why?
|
| Tooth Replantation | 1 | 2006 | 8 | 0.070 |
Why?
|
| Tooth Apex | 1 | 2006 | 27 | 0.070 |
Why?
|
| Veins | 1 | 2011 | 769 | 0.070 |
Why?
|
| Aluminum Compounds | 1 | 2006 | 56 | 0.070 |
Why?
|
| Calcium Compounds | 1 | 2006 | 40 | 0.070 |
Why?
|
| Interleukin-8 | 1 | 2009 | 704 | 0.070 |
Why?
|
| Lipase | 1 | 2008 | 321 | 0.070 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2017 | 2953 | 0.070 |
Why?
|
| Silicates | 1 | 2006 | 49 | 0.070 |
Why?
|
| Root Resorption | 1 | 2006 | 40 | 0.070 |
Why?
|
| Prostate-Specific Antigen | 1 | 2016 | 2463 | 0.070 |
Why?
|
| Teaching | 1 | 2014 | 1171 | 0.070 |
Why?
|
| Wounds and Injuries | 1 | 2019 | 2515 | 0.060 |
Why?
|
| Cardiovascular Diseases | 1 | 2012 | 15662 | 0.060 |
Why?
|
| Amines | 1 | 2007 | 280 | 0.060 |
Why?
|
| Absorbable Implants | 1 | 2008 | 336 | 0.060 |
Why?
|
| Interferon-gamma | 1 | 2014 | 3159 | 0.060 |
Why?
|
| Cryopreservation | 1 | 2011 | 733 | 0.060 |
Why?
|
| RNA Interference | 1 | 2014 | 2830 | 0.060 |
Why?
|
| Bone Matrix | 1 | 2005 | 127 | 0.060 |
Why?
|
| Treatment Outcome | 4 | 2021 | 65360 | 0.060 |
Why?
|
| Cardiomyopathies | 1 | 2017 | 2058 | 0.060 |
Why?
|
| Osteocalcin | 1 | 2005 | 275 | 0.060 |
Why?
|
| Viscoelastic Substances | 1 | 2024 | 21 | 0.060 |
Why?
|
| Receptor, PAR-1 | 1 | 2005 | 109 | 0.060 |
Why?
|
| Blood Vessels | 1 | 2010 | 1110 | 0.060 |
Why?
|
| Pierre Robin Syndrome | 1 | 2006 | 118 | 0.060 |
Why?
|
| Liver Neoplasms | 1 | 2020 | 4362 | 0.060 |
Why?
|
| Neovascularization, Physiologic | 1 | 2012 | 1369 | 0.060 |
Why?
|
| Oxides | 1 | 2006 | 403 | 0.060 |
Why?
|
| Integrins | 1 | 2009 | 842 | 0.060 |
Why?
|
| Proteomics | 1 | 2018 | 3912 | 0.060 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2011 | 3814 | 0.060 |
Why?
|
| Microspheres | 1 | 2007 | 788 | 0.060 |
Why?
|
| Hypoglycemic Agents | 1 | 2017 | 3109 | 0.060 |
Why?
|
| Cost-Benefit Analysis | 1 | 2017 | 5536 | 0.060 |
Why?
|
| Magnetic Resonance Angiography | 1 | 2011 | 1429 | 0.060 |
Why?
|
| Metal Nanoparticles | 1 | 2008 | 406 | 0.060 |
Why?
|
| Urologic Diseases | 1 | 2006 | 246 | 0.060 |
Why?
|
| Pandemics | 2 | 2022 | 8750 | 0.060 |
Why?
|
| Biopsy, Fine-Needle | 1 | 2009 | 1134 | 0.060 |
Why?
|
| Education, Graduate | 1 | 2004 | 75 | 0.060 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2011 | 1942 | 0.060 |
Why?
|
| Colon, Sigmoid | 1 | 2024 | 124 | 0.050 |
Why?
|
| Catheterization | 1 | 2009 | 1430 | 0.050 |
Why?
|
| Molecular Structure | 1 | 2008 | 1883 | 0.050 |
Why?
|
| Antineoplastic Agents, Alkylating | 1 | 2007 | 614 | 0.050 |
Why?
|
| Biopsy | 1 | 2015 | 6786 | 0.050 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 2 | 2024 | 1656 | 0.050 |
Why?
|
| Rats, Inbred Strains | 1 | 2004 | 2087 | 0.050 |
Why?
|
| Fluorescent Dyes | 1 | 2011 | 1929 | 0.050 |
Why?
|
| T-Lymphocytes | 1 | 2021 | 10264 | 0.050 |
Why?
|
| Societies, Scientific | 1 | 2004 | 223 | 0.050 |
Why?
|
| Photography | 1 | 2006 | 537 | 0.050 |
Why?
|
| Cell Polarity | 1 | 2006 | 639 | 0.050 |
Why?
|
| Administration, Intranasal | 1 | 2024 | 485 | 0.050 |
Why?
|
| Lab-On-A-Chip Devices | 2 | 2017 | 445 | 0.050 |
Why?
|
| Models, Animal | 2 | 2019 | 2121 | 0.050 |
Why?
|
| Alkaline Phosphatase | 1 | 2005 | 863 | 0.050 |
Why?
|
| Health Care Sector | 1 | 2004 | 196 | 0.050 |
Why?
|
| Protein Kinase Inhibitors | 2 | 2017 | 5694 | 0.050 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2017 | 4055 | 0.050 |
Why?
|
| Anthracenes | 1 | 2022 | 83 | 0.050 |
Why?
|
| Orthomyxoviridae Infections | 1 | 2024 | 255 | 0.050 |
Why?
|
| Polytetrafluoroethylene | 1 | 2003 | 242 | 0.050 |
Why?
|
| Inservice Training | 1 | 2004 | 375 | 0.050 |
Why?
|
| Tissue Fixation | 1 | 2003 | 245 | 0.050 |
Why?
|
| RNA, Messenger | 2 | 2014 | 12797 | 0.050 |
Why?
|
| Disease Models, Animal | 4 | 2024 | 18345 | 0.050 |
Why?
|
| Osseointegration | 1 | 2003 | 271 | 0.050 |
Why?
|
| Bone Marrow | 2 | 2017 | 2935 | 0.050 |
Why?
|
| Safety | 1 | 2006 | 1159 | 0.050 |
Why?
|
| Peptide YY | 1 | 2022 | 135 | 0.050 |
Why?
|
| Administration, Inhalation | 1 | 2024 | 1169 | 0.050 |
Why?
|
| Speech Intelligibility | 1 | 2021 | 80 | 0.050 |
Why?
|
| Bone Cements | 1 | 2003 | 327 | 0.050 |
Why?
|
| Endocannabinoids | 1 | 2022 | 113 | 0.050 |
Why?
|
| Hepatocytes | 1 | 2008 | 1248 | 0.050 |
Why?
|
| Growth Substances | 1 | 2003 | 759 | 0.050 |
Why?
|
| Animals, Newborn | 1 | 2006 | 2678 | 0.040 |
Why?
|
| Mass Screening | 1 | 2016 | 5458 | 0.040 |
Why?
|
| Pore Forming Cytotoxic Proteins | 1 | 2020 | 130 | 0.040 |
Why?
|
| Macrophages | 1 | 2015 | 5798 | 0.040 |
Why?
|
| Curriculum | 1 | 2014 | 3783 | 0.040 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2006 | 1243 | 0.040 |
Why?
|
| Clinical Protocols | 1 | 2006 | 1443 | 0.040 |
Why?
|
| Image Enhancement | 1 | 2011 | 2880 | 0.040 |
Why?
|
| Lymphocyte Subsets | 1 | 2021 | 313 | 0.040 |
Why?
|
| Random Allocation | 1 | 2004 | 2396 | 0.040 |
Why?
|
| Parents | 1 | 2014 | 3595 | 0.040 |
Why?
|
| Inflammation Mediators | 2 | 2021 | 1892 | 0.040 |
Why?
|
| Somatostatin | 1 | 2022 | 458 | 0.040 |
Why?
|
| Guinea Pigs | 1 | 2021 | 1310 | 0.040 |
Why?
|
| Lung Neoplasms | 1 | 2024 | 13500 | 0.040 |
Why?
|
| Sheep, Domestic | 1 | 2019 | 52 | 0.040 |
Why?
|
| Microscopy, Electron | 1 | 2003 | 2559 | 0.040 |
Why?
|
| Obesity | 1 | 2021 | 13092 | 0.040 |
Why?
|
| Gene Transfer Techniques | 1 | 2024 | 1207 | 0.040 |
Why?
|
| Multiple Myeloma | 1 | 2017 | 5197 | 0.040 |
Why?
|
| Glucagon-Like Peptide 1 | 1 | 2022 | 374 | 0.040 |
Why?
|
| Universities | 1 | 2004 | 1005 | 0.040 |
Why?
|
| Forelimb | 1 | 2019 | 116 | 0.040 |
Why?
|
| Insulin Infusion Systems | 1 | 2020 | 221 | 0.040 |
Why?
|
| Bioprosthesis | 1 | 2003 | 593 | 0.040 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2009 | 3514 | 0.040 |
Why?
|
| Hemolysis | 1 | 2020 | 417 | 0.040 |
Why?
|
| Quinolones | 1 | 2022 | 389 | 0.040 |
Why?
|
| Myocardium | 1 | 2011 | 4788 | 0.040 |
Why?
|
| Femur | 1 | 2004 | 1321 | 0.040 |
Why?
|
| Water | 1 | 2024 | 1421 | 0.040 |
Why?
|
| Actins | 1 | 2005 | 2064 | 0.040 |
Why?
|
| Blood | 2 | 2014 | 599 | 0.040 |
Why?
|
| DNA, Neoplasm | 1 | 2023 | 1742 | 0.040 |
Why?
|
| Career Choice | 1 | 2004 | 769 | 0.040 |
Why?
|
| Decanoic Acids | 2 | 2007 | 69 | 0.040 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2015 | 5717 | 0.040 |
Why?
|
| Laparoscopy | 1 | 2009 | 2042 | 0.040 |
Why?
|
| Quality of Life | 1 | 2019 | 13489 | 0.030 |
Why?
|
| Sensitivity and Specificity | 2 | 2011 | 14718 | 0.030 |
Why?
|
| Gene Expression Regulation | 1 | 2015 | 11930 | 0.030 |
Why?
|
| Heart Defects, Congenital | 1 | 2014 | 4713 | 0.030 |
Why?
|
| Fibrosis | 1 | 2024 | 2080 | 0.030 |
Why?
|
| Chemical Engineering | 1 | 2016 | 15 | 0.030 |
Why?
|
| Swine, Miniature | 1 | 2019 | 972 | 0.030 |
Why?
|
| Doxorubicin | 1 | 2023 | 2234 | 0.030 |
Why?
|
| Microinjections | 1 | 2017 | 319 | 0.030 |
Why?
|
| Biological Availability | 1 | 2017 | 389 | 0.030 |
Why?
|
| Benzylamines | 1 | 2017 | 251 | 0.030 |
Why?
|
| Gene Expression Profiling | 1 | 2012 | 9536 | 0.030 |
Why?
|
| Heterocyclic Compounds | 1 | 2017 | 245 | 0.030 |
Why?
|
| NIH 3T3 Cells | 2 | 2008 | 668 | 0.030 |
Why?
|
| Ligands | 2 | 2014 | 3284 | 0.030 |
Why?
|
| Data Collection | 1 | 2004 | 3325 | 0.030 |
Why?
|
| Bacterial Toxins | 1 | 2020 | 922 | 0.030 |
Why?
|
| Culture Media, Conditioned | 1 | 2016 | 521 | 0.030 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2018 | 20757 | 0.030 |
Why?
|
| Administration, Cutaneous | 1 | 2017 | 716 | 0.030 |
Why?
|
| Protein Transport | 1 | 2020 | 1951 | 0.030 |
Why?
|
| Organogenesis | 1 | 2016 | 214 | 0.030 |
Why?
|
| Disease Susceptibility | 1 | 2021 | 1793 | 0.030 |
Why?
|
| Epidermal Growth Factor | 1 | 2017 | 697 | 0.030 |
Why?
|
| Students | 1 | 2004 | 1745 | 0.030 |
Why?
|
| Blood-Brain Barrier | 1 | 2021 | 1034 | 0.030 |
Why?
|
| Intellectual Property | 1 | 2013 | 32 | 0.030 |
Why?
|
| Age Factors | 1 | 2011 | 18405 | 0.030 |
Why?
|
| Chickens | 1 | 2016 | 845 | 0.030 |
Why?
|
| Lipids | 1 | 2024 | 3342 | 0.030 |
Why?
|
| Adolescent | 3 | 2019 | 89154 | 0.030 |
Why?
|
| Cytokines | 2 | 2021 | 7453 | 0.030 |
Why?
|
| Gastric Bypass | 1 | 2021 | 824 | 0.030 |
Why?
|
| United States | 3 | 2022 | 73033 | 0.030 |
Why?
|
| Electrocardiography | 1 | 2006 | 6411 | 0.030 |
Why?
|
| GTP-Binding Protein alpha Subunits, Gi-Go | 1 | 2012 | 89 | 0.030 |
Why?
|
| Complement Activation | 1 | 2014 | 447 | 0.030 |
Why?
|
| Infant | 1 | 2014 | 36533 | 0.030 |
Why?
|
| Antibody Specificity | 1 | 2014 | 1065 | 0.020 |
Why?
|
| Bone and Bones | 1 | 2003 | 2589 | 0.020 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2020 | 3609 | 0.020 |
Why?
|
| Tooth Injuries | 1 | 2012 | 17 | 0.020 |
Why?
|
| Emergency Service, Hospital | 1 | 2012 | 7940 | 0.020 |
Why?
|
| Internet | 1 | 2004 | 3111 | 0.020 |
Why?
|
| Bone Morphogenetic Proteins | 1 | 2017 | 845 | 0.020 |
Why?
|
| Palate, Hard | 1 | 2012 | 59 | 0.020 |
Why?
|
| Child, Preschool | 1 | 2014 | 42665 | 0.020 |
Why?
|
| Interferon-beta | 1 | 2013 | 349 | 0.020 |
Why?
|
| Transcription, Genetic | 1 | 2005 | 7613 | 0.020 |
Why?
|
| Complement System Proteins | 1 | 2014 | 738 | 0.020 |
Why?
|
| Reference Standards | 1 | 2015 | 1013 | 0.020 |
Why?
|
| Endoscopy | 1 | 2021 | 1854 | 0.020 |
Why?
|
| Cell-Derived Microparticles | 1 | 2012 | 160 | 0.020 |
Why?
|
| Drug Approval | 1 | 2018 | 820 | 0.020 |
Why?
|
| Body Weight | 1 | 2021 | 4628 | 0.020 |
Why?
|
| Luminescent Measurements | 1 | 2012 | 342 | 0.020 |
Why?
|
| Temperature | 2 | 2007 | 2234 | 0.020 |
Why?
|
| Microvilli | 1 | 2010 | 235 | 0.020 |
Why?
|
| Myocardial Infarction | 1 | 2011 | 11519 | 0.020 |
Why?
|
| Lip | 1 | 2012 | 196 | 0.020 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 1 | 2012 | 693 | 0.020 |
Why?
|
| Immunity, Humoral | 1 | 2014 | 610 | 0.020 |
Why?
|
| Mitochondria | 1 | 2023 | 3681 | 0.020 |
Why?
|
| Poisson Distribution | 1 | 2010 | 506 | 0.020 |
Why?
|
| Necrosis | 1 | 2013 | 1616 | 0.020 |
Why?
|
| Mouth Mucosa | 1 | 2012 | 435 | 0.020 |
Why?
|
| Vascular Grafting | 1 | 2011 | 163 | 0.020 |
Why?
|
| Reproducibility of Results | 3 | 2015 | 20218 | 0.020 |
Why?
|
| Ultraviolet Rays | 1 | 2014 | 1104 | 0.020 |
Why?
|
| Tongue | 1 | 2012 | 406 | 0.020 |
Why?
|
| Embryo Research | 1 | 2008 | 38 | 0.020 |
Why?
|
| Microvessels | 1 | 2012 | 585 | 0.020 |
Why?
|
| Point-of-Care Systems | 1 | 2017 | 1238 | 0.020 |
Why?
|
| Protein Binding | 1 | 2020 | 9343 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2021 | 11068 | 0.020 |
Why?
|
| Synapses | 1 | 2017 | 1765 | 0.020 |
Why?
|
| Dicarboxylic Acids | 1 | 2007 | 75 | 0.020 |
Why?
|
| Cell Division | 2 | 2006 | 4473 | 0.020 |
Why?
|
| Sepharose | 1 | 2007 | 102 | 0.020 |
Why?
|
| Drug Stability | 1 | 2007 | 291 | 0.020 |
Why?
|
| Fluorescein-5-isothiocyanate | 1 | 2007 | 221 | 0.020 |
Why?
|
| Silicon | 1 | 2007 | 143 | 0.020 |
Why?
|
| Triglycerides | 1 | 2014 | 2463 | 0.020 |
Why?
|
| SELEX Aptamer Technique | 1 | 2006 | 19 | 0.020 |
Why?
|
| Middle Aged | 4 | 2024 | 223422 | 0.020 |
Why?
|
| Chemistry, Pharmaceutical | 1 | 2007 | 273 | 0.020 |
Why?
|
| Culture Media, Serum-Free | 1 | 2006 | 148 | 0.020 |
Why?
|
| Hydrolysis | 1 | 2007 | 646 | 0.020 |
Why?
|
| Rats, Inbred F344 | 1 | 2007 | 826 | 0.020 |
Why?
|
| Flow Injection Analysis | 1 | 2005 | 21 | 0.020 |
Why?
|
| Alkylating Agents | 1 | 2006 | 132 | 0.020 |
Why?
|
| Adult | 4 | 2024 | 223577 | 0.020 |
Why?
|
| Microscopy | 1 | 2011 | 908 | 0.020 |
Why?
|
| Prospective Studies | 2 | 2021 | 54921 | 0.020 |
Why?
|
| Graft Rejection | 1 | 2019 | 4500 | 0.020 |
Why?
|
| Polyesters | 1 | 2007 | 376 | 0.020 |
Why?
|
| Mitomycin | 1 | 2006 | 261 | 0.020 |
Why?
|
| Models, Chemical | 1 | 2007 | 610 | 0.020 |
Why?
|
| Pregnancy | 1 | 2007 | 30244 | 0.020 |
Why?
|
| Diagnostic Imaging | 1 | 2019 | 3533 | 0.010 |
Why?
|
| Acetaminophen | 1 | 2008 | 551 | 0.010 |
Why?
|
| Heart | 1 | 2017 | 4445 | 0.010 |
Why?
|
| Disease Progression | 1 | 2021 | 13667 | 0.010 |
Why?
|
| Radiography | 1 | 2015 | 6981 | 0.010 |
Why?
|
| Tumor Microenvironment | 1 | 2017 | 3951 | 0.010 |
Why?
|
| Gene Expression | 1 | 2016 | 7597 | 0.010 |
Why?
|
| MicroRNAs | 1 | 2019 | 3804 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2021 | 22286 | 0.010 |
Why?
|
| Equipment Failure Analysis | 1 | 2005 | 845 | 0.010 |
Why?
|
| Cross-Linking Reagents | 1 | 2006 | 693 | 0.010 |
Why?
|
| Platelet Activation | 1 | 2006 | 644 | 0.010 |
Why?
|
| Transcription Factors | 1 | 2022 | 12165 | 0.010 |
Why?
|
| Brain | 2 | 2021 | 27366 | 0.010 |
Why?
|
| Mutation | 1 | 2006 | 30214 | 0.010 |
Why?
|
| Population Surveillance | 1 | 2012 | 2594 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2022 | 26377 | 0.010 |
Why?
|
| Ultrasonography | 1 | 2014 | 6004 | 0.010 |
Why?
|
| Biological Assay | 1 | 2003 | 627 | 0.010 |
Why?
|
| Membrane Glycoproteins | 1 | 2011 | 3710 | 0.010 |
Why?
|
| Models, Anatomic | 1 | 2003 | 680 | 0.010 |
Why?
|
| Young Adult | 2 | 2019 | 60050 | 0.010 |
Why?
|
| Medical Oncology | 1 | 1991 | 2341 | 0.010 |
Why?
|
| Kidney | 1 | 2014 | 7067 | 0.010 |
Why?
|
| Genetic Vectors | 1 | 2008 | 3402 | 0.010 |
Why?
|
| Liver | 1 | 2014 | 7575 | 0.010 |
Why?
|
| Models, Molecular | 1 | 2008 | 5402 | 0.010 |
Why?
|
| Coronary Artery Disease | 1 | 2017 | 6569 | 0.010 |
Why?
|
| Aged | 2 | 2021 | 171453 | 0.010 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2007 | 3780 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2007 | 10757 | 0.010 |
Why?
|
| Base Sequence | 1 | 2006 | 12417 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2019 | 59600 | 0.010 |
Why?
|
| Training Support | 1 | 1991 | 109 | 0.010 |
Why?
|
| Research Support as Topic | 1 | 1991 | 697 | 0.000 |
Why?
|
| Retrospective Studies | 1 | 2012 | 81748 | 0.000 |
Why?
|
| Research | 1 | 1991 | 1979 | 0.000 |
Why?
|